Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarez-Almazor, M. E.
Right arrow Articles by Bruera, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarez-Almazor, M. E.
Right arrow Articles by Bruera, E.
Journal of Clinical Oncology, Vol 20, Issue 8 (April), 2002: 2134-2141
© 2002 American Society for Clinical Oncology

Attitudes of Terminally Ill Cancer Patients About Euthanasia and Assisted Suicide: Predominance of Psychosocial Determinants and Beliefs Over Symptom Distress and Subsequent Survival

By Maria E. Suarez-Almazor, Catherine Newman, John Hanson, Eduardo Bruera

From the Department of Medicine, Baylor College of Medicine, Houston Center for Utilization Studies and Quality of Care, Veterans Affairs Medical Center, and Department of Symptom Control and Palliative Care, M.D. Anderson Cancer Center, Houston, TX; and Palliative Care Unit, Grey Nuns Hospital, Edmonton, Alberta, Canada.

Address reprint requests to Maria E. Suarez-Almazor, MD, PhD, Health Services Research, Baylor College of Medicine, Veterans Affairs Medical Center (Station 152), 2002 Holcombe Blvd, Houston, TX 77030; email: mes{at}bcm.tmc.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: Although euthanasia and physician-assisted suicide (PAS) are controversial issues, the views of those most affected, terminal patients, are seldom explored. Our objective was to assess whether the attitudes about euthanasia/PAS of terminally ill cancer patients were determined by their symptomatic distress.

PATIENTS AND METHODS: We conducted a survey of 100 patients with terminal cancer. Statements related to the legalization of euthanasia/PAS were scored using Likert scales. We also asked patients how often they had considered ending their lives. Their responses were analyzed in relation to disease characteristics, including an assessment of symptomatic severity, sociodemographic features, general beliefs about the suffering of cancer patients, and survival.

RESULTS: Most patients (69%) supported euthanasia or PAS for one or more situations. The association between these attitudes and symptoms was weak, consistent in univariate analysis only for shortness of breath. No significant associations were observed with pain, nausea, well-being, loss of appetite, depression, or subsequent survival. Agreement with euthanasia was significantly related to male sex, lack of religious beliefs, and general beliefs about the suffering of cancer patients and their families. In multivariate analysis, the only characteristics that remained statistically associated with support were the strength of religious beliefs and the perception that patients with cancer are a heavy burden on their families. Frequency of suicidal ideation was associated with poor well-being, depression, anxiety, and shortness of breath, but not with other somatic symptoms such as pain, nausea, and loss of appetite.

CONCLUSION: Symptom intensity had limited impact on the attitudes about euthanasia of terminally ill cancer patients. Our findings suggest that patient views are primarily determined by psychosocial traits and beliefs, as opposed to disease severity or symptomatic distress.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
AS THE POPULATION ages, a substantial increase in the number of cancer deaths is expected.1 Euthanasia and physician-assisted suicide (PAS) are controversial issues, and are often debated in public, professional, and political forums. However, the preferences of those directly affected, terminally ill patients, have seldom been explored. Most studies reporting the end-of-life attitudes of terminally ill cancer patients have focused on suicidal ideation and death wish, or the views of those who request assistance to end their lives from their physicians.2-5 A few have examined the views of cancer patients at large,6-10 and some have reported the views of other patient populations.11-14 For the public at large, support for euthanasia is generally related to concerns about intractable suffering and potential symptom distress in patients with advanced disease, most often pain.15 In patients, these views seem to be related to their beliefs about potential pain and suffering, but not to their current levels of pain.8,9,14 Furthermore, studies reporting patient requests to hasten death are more likely to report as a reason for their requests values such as loss of autonomy rather than physical symptoms.16-18

We have previously reported that patients had views on euthanasia and PAS similar to those held by the public.6 A marked polarization of beliefs was observed, with most patients either strongly agreeing or strongly disagreeing with these interventions. To further investigate potential determinants or correlates of these opposing views, we expanded our original survey by interviewing an additional number of patients with terminal cancer. The objective of this study was to evaluate whether patient attitudes about euthanasia and PAS were determined by the symptomatic burden from their illness. We also examined whether these attitudes were related to the patients’ survival, under the hypothesis that patients closer to the time of death may have different preferences than those expected to live longer.


    PATIENTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
One hundred terminally ill cancer patients seen at one of three sites of the Palliative Care Regional Program in Edmonton, Canada, were included on the study. In Edmonton, palliative care delivery is regionally based. Since Canada has universal health care, all cancer patients in the region are potentially eligible to receive palliative care when they enter the terminal phase. The program delivers care to approximately 80% of patients who die of cancer in the Edmonton area.19 The sample included in this study is representative of terminally ill cancer patients, with symptoms or comorbidities requiring specialized treatment. The initial survey of 62 consecutive patients had been conducted in 1995 and 1996; in that study, the attitudes of patients were compared with those of the public and physicians. All patients had completed a symptomatic evaluation (routine assessment in the Palliative Care Program) but the results had not been analyzed because the sample size was considered to be too small for this objective. An additional 38 patients were included in 1996 and 1997 who were interviewed using the same protocol. Patient inclusion criteria were as follows: terminal cancer defined as locally advanced or metastatic disease nonresponsive to antineoplastic treatment, adequate cognition defined as a mini–mental status score of 24 or higher,20 and English language proficiency.

The sample was consecutively accrued until 100 patients were surveyed. At the time of the survey, 17% were receiving outpatient care and 83% were receiving inpatient care. One hundred thirty-eight patients had been potentially eligible. Of these, 31 patients did not want to participate; in an additional three, the family did not allow us to contact them for the study, two patients were too anxious to complete the survey, and an additional two had just been newly diagnosed with cancer and we felt it was unethical to impose the added stress of the interview on them. The participation rate of potentially eligible patients was 72%.

Survey
All the patients were interviewed by research nurses from the palliative care unit not involved in the clinical care of the patients. The survey was administered face to face to evaluate any psychological distress that would require the termination of the interview.

The survey included six items concerning euthanasia and PAS and three items regarding the suffering of patients with cancer and burden to their families (Table 1). All the items were affirmative statements with Likert-type responses on a 1- to 7-point scale, where 1 = strongly disagree, 7 = strongly agree, and 4 = disagree as much as agree. The first four euthanasia/PAS items presented the statement in relation to a terminally ill cancer patient; the other two presented similar statements asking the patient to consider their preferences if they were terminally ill with cancer. "Don’t know" responses were also analyzed in combination with a score of 4 (neutral). An additional two questions asked patients about suicidal ideation, whether and how often had they considered ending their life in the previous month, with possible responses being never, rarely, sometimes, often, and all the time. For some of the analyses, this item was further categorized as never, rarely/sometimes, and often/all the time.


View this table:
[in this window]
[in a new window]
 
Table 1.  Euthanasia and Physician-Assisted Suicide Statements
 
Symptom Assessment
Symptoms were measured using the Edmonton Symptom Assessment Scale (ESAS), which is derived from the measurement of different symptoms using 0- to 10-cm visual analog scales. The ESAS has been validated in this population and is frequently used in clinical studies as an assessment tool.21,22 Individual symptoms evaluated in the ESAS include pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, sensation of well-being, and shortness of breath. For all items, 0 is absence of the symptom or best possible status, and 10 is worst possible status. An overall distress score is calculated by averaging the individual symptom scores.

Survival
Survival status was determined by examining the medical records of the patients and the regional cancer registry. Duration of survival, calculated as time between the date of the interview and death, was available for 96 patients, who had all died by 1999. We considered survival to be a surrogate for disease severity. Although not necessarily associated with symptom burden, we felt it provided a measure of tumor spread and vital organ involvement, and proximity to death.

Sociodemographic Variables
Additional questions included information in relation to demographic variables, marital status, education, religion, strength of religious beliefs, financial expectations, and family responsibilities. Although income was included in the survey, a large number of patients did not want to answer this question and the variable was dropped from the analysis. Information about changes in financial status was elicited by asking patients if they were financially better, worse, or the same as the year before; we also asked for their financial expectations for the following year. Family responsibilities were elicited with four items, including responsibility for dependents, financial responsibility, and housework. For each of the items, patients were asked if they were solely responsible (score of 1), had shared responsibility (score of 0.5), or had no responsibility (score of 0). The final score ranged from 0 to 4.

Statistical Analysis
Analysis of the data showed a bimodal distribution for most of the euthanasia/PSA items, with the majority of patients either strongly agreeing or disagreeing (an example of this distribution was reported in our previous publication6). Consequently, we used nonparametric tests in addition to parametric testing to evaluate associations and differences in item responses as they related to patient characteristics and belief groups. Each survey item was initially analyzed individually. Because similar trends were observed, we also analyzed the total score of items 1 to 6. Differences between proportions were assessed by {chi}2 (nominal variables) and tau (ordinal variables) tests and Spearman correlation coefficients to assess bivariate associations. Differences in means among groups were assessed with one-way analysis of variance. The analyses included categorized continuous and ordinal variables to determine whether differences, which might be hidden when analyzing these variables as a continuum, occurred for patients with extreme views or with severe symptoms.

Multivariate analysis was performed to evaluate the association of symptomatic disease with euthanasia/PAS attitudes while adjusting for covariates. As indicated above, the responses to the euthanasia and PAS statements tended to be bimodal and, as a result, a linear regression model would be inappropriate. We therefore used a logistic regression model with a dichotomous dependent variable: agreement with euthanasia/PAS versus disagreement/neutral views. A patient was considered to agree with euthanasia or PAS if one or more of items 1 to 6 were scored 5 or higher. The remaining patients were judged to be neutral or to disagree. Independent variables included sociodemographic characteristics, symptom distress, religion and strength of religious beliefs, previous experience with cancer death in family, family responsibilities, and general beliefs about suffering and burden on families (items 7 to 9). The multivariate model initially included variables of interest (eg, symptoms), variables with statistical significance in the bivariate analyses, and potential confounders that we considered to be important irrespective of their statistical significance (eg, age and sex). A stepwise procedure was then used to determine the statistically significant variables for the final model.

Statistical significance was set at P = .05 (two-tailed tests). The statistical analysis was conducted using SAS Version 8 statistical software (SAS Institute, Inc, Cary, NC).

The study was approved by the human research ethics board at the participating institutions. All patients gave written consent before being interviewed.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
One hundred patients, 42 men and 58 women, participated in the survey. Their mean age was 63.2 ± 12.2 years, and mean disease duration from diagnosis was 3.0 ± 4.1 years. No differences were observed between participants and nonparticipants with respect to sex (58% v 63% were women) or age (63.2 v 62.2 years old). Figure 1 shows the patients’ ratings for items 1 to 9. Items 1 to 4 elicited their attitudes in relation to a patient with cancer, and items 5 and 6 in relation to themselves. The responses tended to be polarized, with most individuals agreeing or disagreeing with the statements and only a few (< 10%) remaining neutral. Approximately 50% to 60% of patients agreed with each statement. The mean of the aggregated score of items 1 to 6 was 4.3 ± 2.1 (median, 4.7). Items 7, 8, and 9 related to patient beliefs about physical and emotional suffering of patients with cancer, and burden to their families. A large number of patients responded "don’t know" to the statements about suffering; 80% perceived that patients with cancer were a heavy burden on their families. For some of the analyses, "don’t know" and neutral responses were grouped together.



View larger version (31K):
[in this window]
[in a new window]
 
Fig 1. Responses to items 1 to 9: results are shown as percentage of patients who answered "don’t know," agreed with the statements (Likert responses 5 to 7), were neutral (Likert response 4), or disagreed (Likert responses 1 to 3).

 
Table 2 shows the Spearman correlation coefficients between the responses for items 1 to 9 and patient clinical characteristics. No significant associations were observed between age, disease duration, survival, and euthanasia/PAS items. Correlations between symptoms and euthanasia/PAS views were weak, and the only symptom statistically associated with agreement across most items was shortness of breath. Of the other symptoms, only tiredness and anxiety reached statistical association for selected items.


View this table:
[in this window]
[in a new window]
 
Table 2.  Correlations Between Item Responses, and Symptoms and Other Disease Characteristics (Spearman correlation coefficients)
 
Beliefs about suffering and burden to families were not consistently associated with the patients’ current symptom intensity. Associations reaching statistical significance included depression with emotional and physical suffering (r = .23 and r = .19, respectively), anxiety with physical suffering (r = .22), and appetite with burden to families (r = .20). Thirty-one patients scored all six euthanasia/PAS items as <= 4, and were considered to be in disagreement or neutral. Individuals with one or more scores of 5 were considered to be in agreement, and were further classified into weak to moderate agreement if their overall mean score for the six items was less than 6 (38 patients) and strong agreement if the mean score was >= 6 (31 patients). Figure 2 shows the mean ESAS symptom scores according to this categorization: only shortness of breath and tiredness reached statistical significance.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2. Mean symptom intensity measured with visual analog scales and level of support for euthanasia/PAS. *Statistically significant, P < .05.

 
Table 3 shows the association between euthanasia/PAS views and other patient characteristics and beliefs. The analysis was originally performed for each individual item, but no major discrepancies were observed and the results reported correspond to the aggregated euthanasia/PAS mean score of items 1 to 6. Statistically significant differences were observed for sex and strength of religious beliefs. Men and those with weak or without religious beliefs were more likely to agree with end-of-life measures. No significant differences were observed for age, marital status, organized religious affiliation (Catholic v Protestant/other), financial expectations, previous death in the family, or education. Beliefs that cancer patients are a burden on their families were associated with all the euthanasia/PAS items, with statistically significant correlations ranging from .33 to .48. Perception of physical suffering was statistically correlated with two euthanasia/PAS items (items 3 and 6; r = .21 and .23, respectively) and with the aggregated score (r = .21). The association with perception of emotional suffering was weak (r = .09 to .18 across items) and did not reach statistical significance.


View this table:
[in this window]
[in a new window]
 
Table 3.  Patient Characteristics and Beliefs, and Agreement with Euthanasia/PAS
 
Bivariate and multivariate logistic regression models were performed comparing patients who agreed with at least one of the euthanasia/PAS items with those who were neutral or disagreed. Symptoms were included in the regression dichotomized with a cutoff score of 4 (4 was the approximate median point for many of the symptoms). In the bivariate analysis, statistically significant differences were observed for the following odds ratios (ORs): increasing tiredness (>= 4) (OR = 2.4) (the OR for shortness of breath was 2.3 but did not reach statistical significance); sex, with men being more likely to agree (OR = 2.8); strength of religious beliefs (OR = 0.33 strong v weak or no beliefs); beliefs about the physical and emotional suffering of cancer patients (OR = 1.3 and OR = 1.4 for each point on the 7-point scale); and burden to families (OR = 1.6). In the stepwise multivariate analysis, only religious beliefs and beliefs about burden on families (item 9) remained statistically significant after controlling for symptoms and the other sociodemographic covariates (OR = 0.39 and OR = 1.6, respectively).

When patients were asked how often they had considered ending their lives in the past month, 69 responded never, 15 rarely, 10 sometimes, five often, and one all the time. The correlations between frequency of suicidal ideation and symptoms were weak and did not reach statistical significance: the highest correlation was .18 (P = .07) for well-being (positive association between worse well-being and increased frequency of death thoughts). When the six patients who considered ending their lives often or all the time were analyzed together and compared with those who thought about it rarely or sometimes and those who never had these thoughts, statistically significant differences were observed for well-being, shortness of breath, anxiety, and depression (Fig 3). In general, patients who never, rarely, or sometimes considered death had similar scores, and the differences were determined by the six patients who considered death often. The frequency of suicidal ideation was also significantly associated with all the euthanasia/PAS items (r = .44 for the aggregated score) and beliefs about burden to families (r = .22), but not with beliefs about physical or emotional suffering in cancer patients (r = .15 for both). Men were more likely to have suicidal thoughts than women (43% v 22%, P = .03). Those who had contemplated suicide were more likely to be younger than those who never had these thoughts (59.5 v 64.8 years, P = .05), and more likely to have no religious beliefs. A trend was observed between survival and suicidal ideation: mean survival of those who never thought of ending their lives was 119 days; for those who thought about it rarely/sometimes, 97 days; and for the six patients who had suicidal thoughts often/all the time, 39 days. The difference did not reach statistical significance because of the small number of patients in the last group.



View larger version (25K):
[in this window]
[in a new window]
 
Fig 3. Mean symptom intensity measured with visual analog scales and suicidal ideation. *Statistically significant, P < .05.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The objective of this study was to evaluate whether the attitudes of terminally ill cancer patients were related to the severity of their disease as determined by their symptoms, and their subsequent survival. Most patients agreed with one or more statements about the legalization of euthanasia or PAS. Previous studies in patients with AIDS and terminal cancer have also shown support ranging from 60% to 90% of patients agreeing with euthanasia or PAS for specific patient scenarios.8-12 The subjects in our study were terminally ill cancer patients receiving palliative care in a specialized regional program that provides care for those with complex and severe advanced disease. Nevertheless, we were unable to find a strong relationship between symptom severity or subsequent survival, and euthanasia/PAS views. Overall, only shortness of breath seemed to have a clear impact on patient attitudes. Emanuel et al8 surveyed 155 oncology patients using clinical vignettes and found no relationship between increased pain and support for euthanasia; in fact, patients with pain were more likely to find euthanasia unacceptable, which is similar to the trends for pain found in our study, which did not reach statistical significance. Sullivan et al9 interviewed 48 patients with metastatic cancer and elicited their views about passive and active end-of-life measures. Most patients supported euthanasia or PAS, but these views were not related to their current pain or depression. The presence of one or more somatic depression symptoms in the past was significantly related to support for passive means of ending life but did not reach significance for active measures. The individual symptoms showing the strongest association were feeling tired, sleeping too much, and loss of interest in sex. In our study, tiredness was also associated with support for euthanasia/PAS in the bivariate logistic model. Whether tiredness in this context is a physical manifestation of tumor burden or a symptom of depression cannot be determined. It is widely perceived by supporters that the need for euthanasia/PAS is strongly dictated by unremitting pain.8,9,15 However, studies reporting the reasons for requests to hasten death do not include controls and cannot conclude whether the intensity of pain experienced by patients desiring PAS is different from the pain level of those who do not.17,23 Our results, and the findings by Emmanuel et al8 and Sullivan et al,9 suggest that the intensity of pain and of most other somatic symptoms does not have an impact on patient attitudes.14 The tolerance and acceptance of symptomatic distress for a given level of symptom intensity may differ between supporters and those opposed to these measures, but cannot be determined from our data, because we only used rating scales to measure symptom severity. Shortness of breath was the only somatic symptom consistently associated with patient views in the bivariate analysis. Dyspnea has been cited as a reason for requesting lethal medications in the terminally ill. This is one of the symptoms in cancer patients that is less understood and treated.24 The efficacy of therapeutic interventions for dyspnea relief is poor. Our results suggest that the burden from this symptom is significant, perhaps sufficient to alter patient preferences about euthanasia and PAS.

In our survey, the strongest determinants of euthanasia and PAS attitudes were sociodemographic and cultural characteristics, including sex and religious beliefs. Religious attitudes have been shown in a number of studies to be a strong determinant of public, physician, and patient views.6,8,13,25-28 In addition, in our study, the beliefs that patients had about the suffering and burden on families of cancer patients also had an impact on their views. The desire not to be a burden on others and loss of autonomy are among the most common reasons in requests for assisted suicide.17,18 We found that patient general views about cancer patients being a heavy burden on their families and the strength of their religious beliefs were the only factors that remained significant in the multivariate analysis after controlling for symptoms and other characteristics. These attitudes were not related to the severity of their symptoms or a previous experience of a cancer death in their family. A large proportion of terminally ill patients have care needs that cannot be met by the medical system and rely on help from caregivers29,30; patients with substantial needs are more likely to have considered euthanasia or PAS.30 This burden on others seems to have substantial influence on their views.

Frequency of suicidal ideation was associated with support for euthanasia/PAS but was also related to a number of other disease characteristics. These included depression, anxiety, well-being, and dyspnea. The differences could be attributed mostly to a small percentage of patients (6%) who had persistent death thoughts; no major differences were observed between those who sometimes or never had such thoughts. Chochinov et al31 reported the results of an observational study measuring will to live in cancer patients receiving palliative care, and its relationship to symptom distress using the ESAS. The analysis identified exactly the same four determinants (and no others) found in our study. Emanuel et al8 also reported increased psychological distress in terminal patients who had considered or discussed euthanasia and PAS. We did not perform a multivariate analysis to evaluate the determinants of suicidal ideation because the strongest correlates seemed to be related to psychological distress, and it was unclear to us whether this distress resulted in increased frequency of death thoughts or weather in fact the opposite was true, and frequent suicidal ideation resulted in decreased well-being and increased distress. Limited uncontrolled observational data after PAS was legalized in Oregon in 1997, and anecdotal case series suggest that some patient interventions (in particular, referrals to multidisciplinary or hospice programs) and antidepressant drugs may result in some patients changing their desires about hastening death.16,17,32

An intriguing finding was that survival seemed to be associated with suicidal ideation (but not with euthanasia/PAS views), although the difference did not reach statistical significance. The six patients who often thought about ending their lives died, on average, 39 days after the interview, compared with 119 days for those who never had suicidal thoughts. A number of hypothetical reasons could explain this finding: increased suicidal ideation as death approaches, a deleterious effect on survival from death thoughts, or perhaps active death choice with or without assistance. The one study examining changes in will to live over time showed wide fluctuations, but there was no clear evidence that it decreased as death approached.31

The patients in this study were treated in a palliative care program, which provides care for most patients with symptomatic terminal cancer in Edmonton. It is therefore representative of patients dying from cancer in this region. We do not know whether these findings are generalizable to patients without access to palliative care. Furthermore, patients in our study had universal health care that covered their prescription drugs. This may not be the case in other settings, for instance in the United States, where the cost of oral morphine is not covered by Medicare. The impact of these differences in health systems on patient views cannot be ascertained in our study. Our results, however, seem to be in agreement with the limited literature in other countries examining the determinants of patient support for euthanasia and assisted suicide. The survey used in our study was short and did not incorporate more comprehensive tools to better define depression, anxiety, and other psychosocial variables. In particular, a number of psychosocial constructs such as coping mechanisms, self-efficacy, self-worth, and perceived social support may be crucial to patients’ preferences. In this study, our objective was to evaluate the impact of symptom severity on patient views, and not so much the influence of psychological distress. Our findings suggest, nevertheless, that given the small influence of physical symptoms, psychological and spiritual issues may be more relevant to patient preferences and attitudes and deserve further attention in future studies.

In summary, attitudes about legalization of euthanasia and PAS of most terminally ill cancer patients are not generally determined by the severity of their symptoms. The strongest determinants in our study were psychosocial features such as sex and religious beliefs and general views about suffering in patients with cancer. These findings suggest that, for terminal patients, these attitudes are cultural and ethical constructs not influenced by the severity of their illness. A small number of patients with persistent suicidal thoughts showed increased psychological distress. Therapeutic or psychosocial interventions may modify the desire to hasten death in these patients, but it is unclear whether they may impact individual patient views about legalization of euthanasia and PAS.


    ACKNOWLEDGMENTS
 
Supported in part by the Health Services Research and Development Service of the Department of Veterans Affairs, Washington, DC.

We thank the terminally ill cancer patients who participated in the survey and gave their views despite the distressing nature of the subject. We also thank Robin Fainsinger and Mark Kuebeler.


    NOTES
 
The views expressed herein do not necessarily reflect those of the Department of Veterans Affairs.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
1. Cancer Pain Relief and Palliative Care: Report of the WHO Expert Committee. Geneva, Switzerland, World Health Oganization, 1990

2. Brown J, Henteleff P, Barakat S, et al: Is it normal for terminally ill patients to desire death? Am J Psychiatry 152: 1185-1191, 1995[Abstract/Free Full Text]

3. Owen C, Tennant C, Levi J, et al: Suicide and euthanasia: Patient attitudes in the context of cancer. Psychooncology 1: 79-88, 1992

4. Block SD, Billings JA: Patient requests to hasten death: Evaluation and management in terminal care. Arch Intern Med 154: 2039-2047, 1994[Abstract]

5. Chochinov HM, Wilson KG, Enns M, et al: Desire for death in the terminally ill. Am J Psychiatry 152: 1185-1191, 1995

6. Suarez-Almazor ME, Belzile M, Bruera E: Euthanasia and physician-assisted suicide: A comparative survey of physicians, terminally ill cancer patients, and the general population. J Clin Oncol 15: 418-427, 1997[Abstract/Free Full Text]

7. Owen C, Levi J, Jones M: Cancer patients’ attitudes to final events in life: Wish for death, attitudes to cessation of treatment, suicide and euthanasia. Psychooncology 3: 1-9, 1994

8. Emanuel EJ, Fairclough DL, Daniels ER, et al: Euthanasia and physician-assisted suicide: Attitudes and experiences of oncology patients, oncologists, and the public. Lancet 347: 1805-1810, 1996[CrossRef][Medline]

9. Sullivan M, Rapp S, Fitzgibbon D, et al: Pain and the choice to hasten death in patients with painful metastatic cancer. J Palliat Care 13: 18-28, 1997[Medline]

10. Wolfe J, Fairclough DL, Clarridge BR, et al: Stability of attitudes regarding physician-assisted suicide and euthanasia among oncology patients, physicians, and the general public. J Clin Oncol 17: 1274-1279, 1999[Abstract/Free Full Text]

11. Tindall B, Forde S, Carr A, et al: Attitudes to euthanasia and assisted suicide in a group of homosexual men with advanced HIV disease. J Acquir Immune Defic Syndr 6: 1069-1070, 1993

12. Breitbart W, Rosenfeld BD, Passik SD: Interest in physician-assisted suicide among ambulatory HIV-infected patients. Am J Psychiatry 153: 238-242, 1996[Abstract/Free Full Text]

13. Sullivan M, Ormel J, Kempen GI, et al: Beliefs concerning death, dying, and hastening death among older, functionally impaired Dutch adults: A one-year longitudinal study. J Am Geriatr Soc 46: 1251-1257, 1998[Medline]

14. Ganzini L, Johnston WS, Hoffman WF: Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52: 1434-1440, 1999[Abstract/Free Full Text]

15. Emanuel EJ, Daniels ER, Fairclough DL, et al: The practice of euthanasia and physician-assisted suicide in the United States: Adherence to proposed safeguards and effects on physicians. JAMA 280: 507-513, 1998[Abstract/Free Full Text]

16. Sullivan AD, Hedberg K, Fleming DW: Legalized physician-assisted suicide in Oregon: The second year. N Engl J Med 342: 598-604, 2000[Abstract/Free Full Text]

17. Ganzini L, Nelson HD, Schmidt TA, et al: Physicians’ experiences with the Oregon Death with Dignity Act. N Engl J Med 342: 557-563, 2000[Abstract/Free Full Text]

18. Back AL, Wallace JI, Starks HE, et al: Physician-assisted suicide and euthanasia in Washington State: Patient requests and physician responses. JAMA 275: 919-925, 1996[Abstract]

19. Bruera E, Neuman CM, Gagnon B, et al: Edmonton Regional Palliative Care Program: Impact on patterns of terminal cancer care. Can Med Assoc J 161: 290-293, 1999[Abstract/Free Full Text]

20. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975[CrossRef][Medline]

21. Bruera E, Kuehn N, Miller M, et al: The Edmonton symptom assessment system (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 7: 6-9, 1991[Medline]

22. Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer 80: 2164-2171, 2000

23. Foley KM: The relationship of pain and symptom management to patient requests for physician-assisted suicide. J Pain Symptom Manage 6: 289-297, 1991[CrossRef][Medline]

24. Higginson J, McCarthy M: Measuring symptoms in terminal cancer: Are pain and dyspnea controlled? J R Soc Med 82: 264-267, 1989[Abstract]

25. Baume P, O’Malley E, Bauman A: Professed religious affiliation and the practice of euthanasia. J Med Ethics 21: 49-54, 1995[Abstract]

26. Cicirelli VG: Relationship of psychosocial and background variables to older adults’ end-of-life decisions. Psychol Aging 12: 72-83, 1997[CrossRef][Medline]

27. Lichtenstein RL, Alcser KH, Corning AD, et al: Black/white differences in attitudes toward physician-assisted suicide. J Natl Med Assoc 89: 125-133, 1997[Medline]

28. Grassi L, Magnani K, Ercolani M: Attitudes toward euthanasia and physician-assisted suicide among Italian primary care physicians. J Pain Symptom Manage 17: 188-196, 1999[CrossRef][Medline]

29. Emanuel EJ, Fairclough DL, Slutsman J, et al: Assistance from family members, friends, paid care givers and volunteers in the care of terminally ill patients. N Engl J Med 341: 956-963, 1999[Abstract/Free Full Text]

30. Emanuel EJ, Fairclough DL, Slutsman J, et al: Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers. Ann Intern Med 132: 451-459, 2000[Abstract/Free Full Text]

31. Chochinov HM, Tataryn D, Clinch JJ, et al: Will to live in the terminally ill. Lancet 354: 816-819, 1999[Medline]

32. Kugaya A, Akechi T, Nakano T, et al: Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Support Care Cancer 7: 432-436, 1999[CrossRef][Medline]

Submitted October 11, 2000; accepted January 3, 2002.




This article has been cited by other articles:


Home page
Palliat MedHome page
J Pereira, P Laurent, B Cantin, D Petremand, and T Currat
The response of a Swiss university hospital's palliative care consult team to assisted suicide within the institution
Palliative Medicine, July 1, 2008; 22(5): 659 - 667.
[Abstract] [PDF]


Home page
Ann OncolHome page
M Sanjo, M Miyashita, T Morita, K Hirai, M Kawa, T Akechi, and Y Uchitomi
Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan
Ann. Onc., September 1, 2007; 18(9): 1539 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Eur J Public HealthHome page
J. Cohen, I. Marcoux, J. Bilsen, P. Deboosere, G. van der Wal, and L. Deliens
Trends in acceptance of euthanasia among the general public in 12 European countries (1981-1999)
Eur J Public Health, December 1, 2006; 16(6): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
P. L Hudson, L. J Kristjanson, M. Ashby, B. Kelly, P. Schofield, R. Hudson, S. Aranda, M. O'Connor, and A. Street
Desire for hastened death in patients with advanced disease and the evidence base of clinical guidelines: a systematic review.
Palliative Medicine, October 1, 2006; 20(7): 693 - 701.
[Abstract] [PDF]


Home page
JAMAHome page
D. P. Sulmasy
Spiritual issues in the care of dying patients: ". . . it's okay between me and god".
JAMA, September 20, 2006; 296(11): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
G. T. Carter, G. K. VandeKieft, and D. W. Barron
Whose life is it, anyway? The federal government vs. the state of Oregon on the legality of physician-assisted suicide
American Journal of Hospice and Palliative Medicine, July 1, 2005; 22(4): 249 - 251.
[PDF]


Home page
AM J HOSP PALLIAT CAREHome page
J. D. Cowan, D. Burns, T. W. Palmer, J. Scott, and E. Feeback
A palliative medicine program in a community setting: 12 points from the first 12 months
American Journal of Hospice and Palliative Medicine, November 1, 2003; 20(6): 415 - 433.
[Abstract] [PDF]


Home page
Palliat MedHome page
M. Maltoni
From Italy
Palliative Medicine, March 1, 2003; 17(2): 139 - 140.
[PDF]


Home page
Palliat MedHome page
J. Pereira
From Canada
Palliative Medicine, March 1, 2003; 17(2): 167 - 168.
[PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarez-Almazor, M. E.
Right arrow Articles by Bruera, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarez-Almazor, M. E.
Right arrow Articles by Bruera, E.

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online